Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CNTY
CNTY logo

CNTY Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Century Casinos Inc (CNTY) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.430
1 Day change
-1.38%
52 Week Range
2.850
Analysis Updated At
2026/03/13
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Century Casinos Inc (CNTY) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. The stock's technical indicators are bearish, and the financial performance shows declining revenue and negative net income, despite some YoY improvements. While options data shows a bullish sentiment with a low Put-Call ratio, the lack of strong positive catalysts and no recent Intellectia Proprietary Trading Signals suggest holding off on buying this stock for now.

Technical Analysis

The technical indicators for CNTY are bearish. The MACD is below zero and negatively expanding, the RSI is neutral at 28.33, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 1.432, with resistance at 1.555. The stock has a 50% chance of moving slightly up (1.57%) in the next day but is more likely to decline over the next week (-3.72%) and month (-0.4%).

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
11
Buy
4

Positive Catalysts

  • Options data indicates bullish sentiment with a low Put-Call ratio. Analysts have raised price targets recently, and the company has sufficient cash runway to fund operations until Q1 2029.

Neutral/Negative Catalysts

  • The stock is in a bearish technical trend, with declining revenue (-1.27% YoY) and negative net income (-$10.55M). Gross margin has also decreased (-2.01% YoY). No recent congress trading data or Intellectia Proprietary Trading Signals are present. Analyst price targets were adjusted downward due to dilution concerns.

Financial Performance

In Q3 2025, revenue dropped by -1.27% YoY to $153.72M. Net income improved by 29.92% YoY but remains negative at -$10.55M. EPS increased by 34.62% YoY to -0.35, and gross margin declined to 37.07%, down -2.01% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are cautiously optimistic, with Piper Sandler raising the price target to $4 from $2 and maintaining an Overweight rating. Clear Street lowered the price target to $6.60 from $8 but kept a Buy rating, citing dilution concerns offset by increased pipeline success likelihood.

Wall Street analysts forecast CNTY stock price to rise
2 Analyst Rating
Wall Street analysts forecast CNTY stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.450
sliders
Low
4
Averages
4
High
4
Current: 1.450
sliders
Low
4
Averages
4
High
4
Piper Sandler
NULL
to
Overweight
upgrade
$2 -> $4
AI Analysis
2026-01-20
Reason
Piper Sandler
Price Target
$2 -> $4
AI Analysis
2026-01-20
upgrade
NULL
to
Overweight
Reason
Piper Sandler raised the firm's price target on Century Therapeutics to $4 from $2 and keeps an Overweight rating on the shares. The firm notes Century plans to submit an IND for CNTY-813 this year and report initial data in 2027. Piper estimates Century now hold pro forma cash of about $267M to fund operations into Q1 2029.
Clear Street
Bill Maughan
Buy
downgrade
$8
2026-01-08
Reason
Clear Street
Bill Maughan
Price Target
$8
2026-01-08
downgrade
Buy
Reason
Clear Street analyst Bill Maughan lowered the firm's price target on Century Therapeutics to $6.60 from $8 and keeps a Buy rating on the shares. The private placement brings the runway out to 1Q29, allowing for development of a fuller picture of the true potential of lead asset CNTY-813 before needing additional capital, the analyst tells investors in a research note. The firm added that it is reducing its price target on dilution from the raise, offset by increased pipeline likelihood of success and peak sales.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CNTY
Unlock Now

People Also Watch